Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Global health R&D delivers forPennsylvania

Map
Pennsylvania
Select a new state
Select a State
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois
Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana
Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island
South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

US government investment in global health R&D has delivered

$352.8 million
to Pennsylvania research institutions
4,300+ new jobs
for Pennsylvania
Pennsylvania

Neglected diseases in Pennsylvania

Chikungunya cases
Chikungunya cases
111
Dengue cases
Dengue cases
133
HIV diagnoses
HIV diagnoses
12669
Malaria cases
Malaria cases
448
Tuberculosis cases
Tuberculosis cases
2150
West Nile cases
West Nile cases
178
Zika cases
Zika cases
52
Pennsylvania's top USG-funded global health R&D institutions

Pennsylvania's top USG-funded global health R&D institutions

Magee-Womens Research Institute & Foundation
$107.3 million
University of Pennsylvania
$95.2 million
University of Pittsburgh
$69.2 million
Pennsylvania State University
$24.4 million
Drexel University
$20.4 million
Wistar Institute
$18.5 million
Thomas Jefferson University
$5.8 million
Particles Sciences
$3.4 million
Fox Chase Cancer Center/Institute for Cancer Research Philadelphia
$2.5 million
Children's Hospital of Philadelphia
$2.3 million
Baruch S. Blumberg Institute
$950 thousand
Duquesne University
$943 thousand
Philadelphia Research and Education Foundation
$651 thousand
Lehigh University
$451 thousand
Children's Hospital Pittsburgh - UPMC Health Systems
$408 thousand
Villanova University
$245 thousand
Temple University
$214 thousand
Pennsylvania Drug Discovery Institute
$204 thousand
Pennsylvania industry in global health R&D

Pennsylvania industry in global health R&D

Actuated Medical
Location(s): Bellafonte
AstraZeneca
Location(s): Philadelphia
Bayer
Location(s): Pittsburgh
Charles River Laboratories
Location(s): Horsham, King of Prusssia, Malvern
Fox Chase Chemical Diversity Center
Location(s): Doylestown
GSK
Location(s): Philadelphia, Upper Merion, Upper Providence
Hydas World Health
Location(s): Hummelstown
Immunotope
Location(s): Doylestown
Inovio Pharmaceuticals
Location(s): Plymouth Meeting
Integral Molecular
Location(s): Philadelphia
Janssen
Location(s): Horsham, Malvern, Spring House
L.E.A.F. Pharmaceuticals
Location(s): Woburn
Lenima Field Diagnostics
Location(s): Philadelphia
LIMR Chemical Genomics Center
Location(s): Wynnewood
Lipella Pharmaceuticals
Location(s): Philadelphia
Medical Avatar
Location(s): Pittsburgh
Merck & Co
Location(s): Upper Gwynedd, West Point
Novartis
Location(s): Sinking Spring
Phelix Therapeutics
Location(s): Philadelphia
Sanofi
Location(s): Malvern
VentoRx Pharmacueticals
Location(s): Malvern
Westat
Location(s): Philadelphia

Pennsylvania's top areas of global health R&D by USG funding

55.7%
HIV/AIDS
12.1%
Malaria
10.1%
Tuberculosis
3.5%
Diarrheal diseases
12.7%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
Trachoma
5.9%
Other
Bacterial pneumonia & meningitis
Ebola/viral hemorrhagic fevers
Non-allocable
Salmonella infections
Global health R&D at work in Pennsylvania
Global health R&D at work in Pennsylvania

Once HIV therapy is working, HIV can lie dormant in immune cells at low levels. It is critical to determine if this latent HIV reservoir, often containing damaged HIV, could create more virus and cause relapse if treatment is stopped. Now researchers at the University of Pittsburgh have created a test to detect this “hidden” HIV. The test is faster, easier on patients, less labor-intensive, less expensive, and more sensitive than the current gold-standard test.

Download PDF
Map
Select a new state
Footnotes
  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: PATH/Scott Areman
Close
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In